BlackRock Inc. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$1,138,209,000
+127.5%
13,385,970
-5.2%
0.04%
+110.0%
Q2 2020$500,208,000
+135.2%
14,114,226
-10.5%
0.02%
+100.0%
Q1 2020$212,687,000
-31.6%
15,777,893
+7.4%
0.01%
-16.7%
Q4 2019$310,978,000
+64.7%
14,696,596
+3.2%
0.01%
+50.0%
Q3 2019$188,769,000
-1.4%
14,236,069
+3.2%
0.01%0.0%
Q2 2019$191,389,000
-20.7%
13,798,803
+9.9%
0.01%
-27.3%
Q1 2019$241,265,000
+33.8%
12,559,341
-0.6%
0.01%
+22.2%
Q4 2018$180,363,000
-29.0%
12,639,350
+3.6%
0.01%
-18.2%
Q3 2018$254,206,000
-4.4%
12,203,782
+8.7%
0.01%
-8.3%
Q2 2018$265,786,000
+101.4%
11,228,828
+24.3%
0.01%
+100.0%
Q1 2018$131,983,000
-9.9%
9,033,762
-0.3%
0.01%
-14.3%
Q4 2017$146,478,000
+25.8%
9,064,259
+8.8%
0.01%
+16.7%
Q3 2017$116,420,000
+60.2%
8,327,651
+1.2%
0.01%
+50.0%
Q2 2017$72,692,000
+41.9%
8,232,443
+4.0%
0.00%
+33.3%
Q1 2017$51,220,000
+159962.5%
7,916,493
+92631.6%
0.00%
Q4 2016$32,000
+14.3%
8,537
-1.1%
0.00%
Q3 2016$28,000
+40.0%
8,6300.0%0.00%
Q2 2016$20,000
+42.9%
8,630
+57.2%
0.00%
Q1 2016$14,000
+133.3%
5,489
+197.5%
0.00%
Q4 2015$6,000
+100.0%
1,8450.0%0.00%
Q3 2015$3,000
-57.1%
1,8450.0%0.00%
Q2 2015$7,000
-12.5%
1,845
-16.7%
0.00%
Q1 2015$8,000
-27.3%
2,2150.0%0.00%
Q4 2014$11,000
+37.5%
2,2150.0%0.00%
Q3 2014$8,0000.0%2,2150.0%0.00%
Q2 2014$8,000
-11.1%
2,215
+6.8%
0.00%
Q1 2014$9,000
-10.0%
2,0740.0%0.00%
Q4 2013$10,000
-23.1%
2,0740.0%0.00%
Q3 2013$13,000
+18.2%
2,0740.0%0.00%
Q2 2013$11,0002,0740.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders